Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

A dissection of the CD45/side scatter "blast gate".

Harrington AM, Olteanu H, Kroft SH.

Am J Clin Pathol. 2012 May;137(5):800-4. doi: 10.1309/AJCPN4G1IZPABRLH.

2.

The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders.

Harrington A, Olteanu H, Kroft S.

Am J Clin Pathol. 2010 Nov;134(5):749-61. doi: 10.1309/AJCPFNF5MN1GDWKU.

3.

Immunophenotypic clustering of myelodysplastic syndromes.

Maynadié M, Picard F, Husson B, Chatelain B, Cornet Y, Le Roux G, Campos L, Dromelet A, Lepelley P, Jouault H, Imbert M, Rosenwadj M, Vergé V, Bissières P, Raphaël M, Béné MC, Feuillard J; Groupe d'Etude Immunologique des Leucémies (GEIL)..

Blood. 2002 Oct 1;100(7):2349-56.

4.
6.

Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?

Subirá D, Font P, Villalón L, Serrano C, Askari E, Góngora E, Castañón S, Gonzalo R, Mata R, Román A, Llamas P.

Transl Res. 2008 May;151(5):240-5. doi: 10.1016/j.trsl.2008.03.001.

PMID:
18433705
7.

Immunophenotypic features of granulocytes, monocytes, and blasts in myelodysplastic syndromes.

Moon HW, Huh JW, Lee M, Hong KS, Chung WS.

Korean J Lab Med. 2010 Apr;30(2):97-104. doi: 10.3343/kjlm.2010.30.2.97.

9.

Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.

van de Loosdrecht AA, Westers TM, Westra AH, Dräger AM, van der Velden VH, Ossenkoppele GJ.

Blood. 2008 Feb 1;111(3):1067-77.

10.
12.

Immunophenotypic pattern of myeloid populations by flow cytometry analysis.

Gorczyca W, Sun ZY, Cronin W, Li X, Mau S, Tugulea S.

Methods Cell Biol. 2011;103:221-66. doi: 10.1016/B978-0-12-385493-3.00010-3. Review.

PMID:
21722806
13.

GCSF-R expression in myelodysplastic and myeloproliferative disorders and blast dysmaturation in CML.

Hanumanthu VS, Pirruccello SJ.

Am J Clin Pathol. 2013 Aug;140(2):155-64. doi: 10.1309/AJCPCLHZR5KUHUBM.

15.

Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study.

Ogata K, Della Porta MG, Malcovati L, Picone C, Yokose N, Matsuda A, Yamashita T, Tamura H, Tsukada J, Dan K.

Haematologica. 2009 Aug;94(8):1066-74. doi: 10.3324/haematol.2009.008532.

16.

Flow cytometric immunophenotyping of lymphocyte subsets in samples that contain a high proportion of non-lymphoid cells.

Pattanapanyasat K, Kyle DE, Tongtawe P, Yongvanitchit K, Fucharoen S.

Cytometry. 1994 Dec 15;18(4):199-208.

17.

Childhood acute erythroleukemia diagnosis by flow cytometry.

Sharma A, Buxi G, Walia R, Yadav RB, Sharma S.

Indian J Pathol Microbiol. 2011 Jan-Mar;54(1):173-5. doi: 10.4103/0377-4929.77395.

18.

[CD45-gating for flow cytometric immunophenotyping of leukemia].

Cui W, Ma W, Lin Q.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000 Apr;22(2):199-203. Chinese.

PMID:
12903529
19.

Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia.

Kussick SJ, Fromm JR, Rossini A, Li Y, Chang A, Norwood TH, Wood BL.

Am J Clin Pathol. 2005 Aug;124(2):170-81.

20.

[CD45 gating of acute leukemia].

Nishikawa K, Miyasaki T, Tsukaguchi N, Noma Y, Nakagawa K, Narita N.

Rinsho Byori. 1996 Jun;44(6):548-53. Japanese.

PMID:
8752733
Items per page

Supplemental Content

Support Center